ARTICLE | Company News
Demegen, Pacgen deal
March 28, 2005 8:00 AM UTC
PRVG granted Pacgen a license to a group of peptides to treat oral diseases. PRVG previously filed an IND for the deal's lead compound for oral candidiasis. Financial terms were not disclosed. ...